Article
Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate.
Clinical biochemistry - 1 May 2001
Neuman M G, Blendis L M, Shear N H, Malkiewicz I M, Ibrahim A, Katz G G, Sapir D, Halpern Z, Brill S, Peretz H, Magazinik S, Konikoff F M
Abstract excerpt
OBJECTIVE: (i) to characterize the profile of tumor necrosis factor alpha (TNF alpha), interleukin-6 (IL-6), IL 10, Fas-ligand and transforming growth factor beta (TGF beta), chronic hepatitis C (HCV) patients with genotype 1; (ii) to determine the influence of triple therapy (TT) with interferon alpha (IFN alpha) + ribavirin + ursodeoxycholic acid on these cytokines and (iii) to establish the relationship...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.